• 1
    Mouraviev V,Polascik TJ. Evolution of Whole Gland Cryosurgery to Focal Ablative Therapy for the Treatment of Localized Prostate Cancer Using Third Generation Cryotechnology. Issues in Urology, 2007:in press
  • 2
    Bahn DK,Silverman P,Lee FSr,Badalament R,Bahn ED,Rewcastle JC. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol. 2006; 20: 688692.
  • 3
    Akduman B,Barqawi AB,Crawford ED. Minimally invasive surgery in prostate cancer: current and future perspectives. Cancer J. 2005; 11: 355361.
  • 4
    Barqawi A,Crawford ED. Focal therapy in prostate cancer: future trends. BJU Int. 2005; 95: 273274.
  • 5
    Cheng L,Jones TD,Pan CX,Barbarin A,Eble JN,Koch MO. Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol. 2005; 18: 10221026.
  • 6
    Onik G,Narayan P,Vaughan D,Dineen M,Brunelle R. Focal “nerve-sparing” cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002; 60: 109114.
  • 7
    Ohori M,Eastham JA,Koh H,Kuroiwa K,Slawin K,Wheeler TM, et al.: Is focal therapy reasonable in patients with early stage prostate cancer (CAP)-an analysis of radical prostatectomy (RP) specimens. J Urol. 2006; 175( suppl): 507. (Abstract 1574)
  • 8
    Masson P,Prepelica K,Lambert EH,McKiernan JM,Benson MC,Olsson CA, et al. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. J Urol. 2005; 173( suppl.): 179.
  • 9
    Davidson PJ. Diagnosis, prognosis and management of incidentally found prostate cancer. Urol Res. 1993; 21: 18.
  • 10
    Hoedemaeker RF,Rietbergen JB,Kranse R,Schroder FH,van der Kwast TH. Histopathological prostate cancer characteristics at radical prostatectomy after population-based screening. J Urol. 2000; 164: 411415.
  • 11
    Boccon-Gibod LM,Dumonceau O,Toublanc M,Ravery V,Boccon-Gibon LA. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Eur Urol. 2005; 48: 895899.
  • 12
    Epstein JI,Sanderson H,Carter HB,Scharfstein DO. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology. 2005; 66: 356360.
  • 13
    Boccon-Gibod LM,de Longchamps NB,Toublanc M,Boccon-Gibod LA,Ravery V. Prostate saturation biopsy in the reevaluation of microfocal prostate cancer. J Urol. 2006; 176: 961963.
  • 14
    Patel U. TRUS and prostate biopsy: current status. Prostate Cancer Prostatic Dis. 2004; 7: 208210.